Mirum Pharmaceuticals

MIRM

114.2001.04% ( +1.170 )

Closed: Jul 27, 16:00:00 (EDT)

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Mirum Pharmaceuticals(MIRM) predict that the Revenue is 159.88 M (+43.28%), Beat estimate;the EBIT is -789.47 M (-5100%), Miss estimate;the EPS is -13.43 (-4377%), Miss estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueExceed expectations

0.16B43.28%

0.15B32.82%

+0.01B10.46%

EBITMiss expectations

-0.79B5099.66%

-0.02B52.57%

-0.77B5,047.09%

EPSMiss expectations

-13.434376.67%

-0.365621.85%

-13.06444,354.82%

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD